4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-001577
President and CEO gave up 40,880 shares (to pay taxes)
- President and CEO acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2019-01-01 | Option exercise | +100,000 | 100,000 | D: show line 1 in the form | ||
| Culley Brian M President and CEO | 2019-01-01 | Shares withheld for taxes | −40,880 | $0.91 | $37,323 | 59,120 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2019-01-01 | Option exercise · Restricted Stock Units | −100,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…